Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-1507-2020

Drug recall · August 26, 2020

Elitek (rasburicase) for injection recall

Why: Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75

Lots / codes

Lot #: A9306, Exp 2/28/2022

Quantity
7451 vials
Company
Sanofi-Aventis U.S. LLC, Bridgewater, NJ
Distribution
Nationwide in the US
Initiated
August 10, 2020 · Voluntary: Firm initiated
Classified
August 17, 2020
Reported
August 26, 2020
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.